COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 139 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $696,000 | -5.2% | 34,200 | -13.0% | 0.01% | +40.0% |
| Q4 2021 | $734,000 | -11.7% | 39,300 | -6.7% | 0.01% | -44.4% |
| Q3 2021 | $831,000 | +4.0% | 42,100 | +24.6% | 0.01% | +12.5% |
| Q2 2021 | $799,000 | +45.3% | 33,800 | +45.7% | 0.01% | +60.0% |
| Q1 2021 | $550,000 | +5.2% | 23,200 | -11.1% | 0.01% | 0.0% |
| Q4 2020 | $523,000 | -15.1% | 26,100 | -11.8% | 0.01% | -28.6% |
| Q3 2020 | $616,000 | -10.2% | 29,600 | -24.5% | 0.01% | -12.5% |
| Q2 2020 | $686,000 | +25.9% | 39,200 | +17.4% | 0.01% | 0.0% |
| Q1 2020 | $545,000 | -31.0% | 33,400 | -13.0% | 0.01% | -11.1% |
| Q4 2019 | $790,000 | +62.6% | 38,400 | -9.2% | 0.01% | +80.0% |
| Q3 2019 | $486,000 | +203.8% | 42,300 | +299.1% | 0.01% | +150.0% |
| Q1 2019 | $160,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |